Oncology Institute Inc (TOI)

The Oncology Institute, Inc. is a healthcare company focused on oncology services in the United States. Through its three operating segments—Specialty Pharmacy, Patient Services, and Clinical Trials & Other—it provides physician services, in-house infusion, specialty pharmacy dispensing, clinical trial management, radiation therapy, and outpatient blood product transfusion services. The company also supports patients with educational seminars, counseling, support groups, and around-the-clock assistance. In addition, it operates community clinics and infusion suites and offers palliative care programs. Its specialty pharmacy provides both in-office and mail-order access to oral and self-injectable medications used alongside cancer treatment. The Oncology Institute serves adult and senior cancer patients and was founded in 2007. It is headquartered in Cerritos, California, and its common stock is listed on Nasdaq under the ticker TOI.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-TOI
$5.08
4.6% Upside
Fair
$8.40
72.8% Upside
Bargain
Good
0.0%
0.9x
485.9 M
560.6 M
17.8%
87.3%
2.2
70.8%
Valuation • Fair Value

Oncology Institute Inc (NASDAQ-TOI) Fair Value by Valuation Model

Review the available estimates for Oncology Institute Inc (NASDAQ-TOI), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$5.08

Estimated upside of 4.6% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$6.41

Discounted cash flow valuation reference.

Comps Fair Value

$3.98

Comparable-company valuation reference.

Analyst Price Target

$8.40

Analysts imply upside of 72.8%.

How to read these valuation models

Use the 5 available valuation references for Oncology Institute Inc (NASDAQ-TOI) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Oncology Institute Inc (NASDAQ-TOI)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

545.8 M

Current operating scale indicator.

Revenue Forecast

647.1 M

Forward revenue estimate.

EBITDA

-25.909 M

Current operating profitability reference.

EBITDA Forecast

5.154 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Oncology Institute Inc (NASDAQ-TOI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Oncology Institute Inc (NASDAQ-TOI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.78

No elevated caution signal from this screen.

Altman Z-Score

2.2

Intermediate risk zone.

FCF / Net Income

70.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Oncology Institute Inc (NASDAQ-TOI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Oncology Institute Inc (NASDAQ-TOI)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Oncology Institute Inc (NASDAQ-TOI). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

Oncology Institute Inc (NASDAQ-TOI) Stock Forecast & Technical Outlook

Review Oncology Institute Inc (NASDAQ-TOI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Oncology Institute Inc (NASDAQ-TOI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Oncology Institute Inc (NASDAQ-TOI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Oncology Institute Inc (NASDAQ-TOI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Oncology Institute Inc (NASDAQ-TOI) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Oncology Institute Inc (NASDAQ-TOI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Oncology Institute Inc (NASDAQ-TOI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Oncology Institute Inc (NASDAQ-TOI) has a Strong Buy consensus, with 4 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 4
Hold 0
Sell 0
FAQ Fast Investor Answers

Oncology Institute Inc (NASDAQ-TOI) Stock FAQ

Data-supported answers about Oncology Institute Inc (NASDAQ-TOI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$5.08
Estimated upside 4.6%
Valuation Rating
Undervalued
Estimated upside of 4.6%
Analyst Target
$8.40
Implied upside 72.8%
Financial Health
Good
Current financial-health read

The current fair value estimate for Oncology Institute Inc (NASDAQ-TOI) is $5.08. This implies an estimated upside of 4.6% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 4.6% versus the current market price.

The available analyst price target for Oncology Institute Inc (NASDAQ-TOI) is $8.40. The analyst target implies estimated upside of 72.8%.

The current financial health read for Oncology Institute Inc (NASDAQ-TOI) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Oncology Institute Inc (NASDAQ-TOI).

The current market capitalization listed for Oncology Institute Inc is 485.9 M.

The current enterprise value listed for Oncology Institute Inc is 560.6 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Oncology Institute Inc is NASDAQ-TOI, and the stock is listed on NASDAQ.

Oncology Institute Inc (NASDAQ-TOI) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Oncology Institute Inc is 17.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Oncology Institute Inc is 87.3%. Free float helps investors understand how much of the share base is available for public trading.